Clinical Study

A Study Measuring The Impact Of A Proteomic Assay In Distinguishing Bipolar I Disorder, Bipolar II Disorder, And Major Depressive Disorder In People Who Are Currently Depressed

Posted Date: Feb 24, 2016

  • Investigator: Susan Lynn Mcelroy
  • Co-Investigator: Katiliya Mundo
  • Specialties: Psychiatry/Psychology, Bipolar Disorder
  • Type of Study: Observational/Survey

The Lindner Center of HOPE is conducting a research study that will evaluate people in a current depressive episode. Participants will be treated under the direction of their doctor and provide 3 blood samples during the study. The purpose of the study is to examine if unipolar depression, bipolar I or bipolar II depression can be determined from a blood sample. The study will last 9 weeks (6 visits during that time). Participants will receive treatment from their regular doctor and not from the study.

Criteria:

Adults 18 To 70 Who Have Been Diagnosed With Major Depression, Bipolar Type I Or Bipolar Type Ii Disorder And Currently Depressed May Be Eligible To Participate.

Keywords:

Mania, Mood Change, Bipolar Disorder, Psychiatry , Manic Depression

For More Information:

Brian Martens
(513) 536-0707
brian.martens@lindnercenter.org

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.